Multi-centered Liraglutide observational study by CGMS in West-Tokyo area

Multi-centered Liraglutide observational study by CGMS in West-Tokyo area - Liraglutide observational CGMS study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003561

Enrollment

Registered

2010-10-15

Start date

2010-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type2 diabetes

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c more than 6.5%, Type 2 diabetes, diet and exercise alone or prescribed surfonyl urea, 20 year-old or older, capable of injecting by themselves.

Exclusion criteria

Exclusion criteria: Serious hypoglycemia, serious diabetic retinopathy, serious heart failure, with malignant tumor, pregnant, prescribed TZD or glinide.

Design outcomes

Primary

Measure	Time frame
Time of blood glucose more than 180mg/dl, and less than 70mg/dl, mean blood glucose, max and minimum blood glucose, standard deviation of blood glucose and its change.	—

Countries

Japan

Contacts

Public ContactTakaichi Miyakawa, Yuko Watanabe, Hitomi Fujii

Tama-center Mirai Clinic Internal Medicine

irb-mirai@tama-mirai.com042-316-8570

Outcome results